Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a serious and fatal pulmonary inflammatory disease with an increasing incidence worldwide. The drugs nintedanib and pirfenidone, are listed as conditionally recommended drugs in the "Evidence-Based Guidelines for the Diagnosis and Treatment of Idiopathic P...
Saved in:
Main Authors: | Peng Lu (Author), Jiawei Li (Author), Chuanxin Liu (Author), Jian Yang (Author), Hui Peng (Author), Zhifeng Xue (Author), Zhidong Liu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
by: S. Chennakesavulu, et al.
Published: (2018) -
Novel Dry Hyaluronic Acid-Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis
by: María S. Magi, et al.
Published: (2024) -
Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis
by: Xiaoxuan Han, et al.
Published: (2023) -
Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery
by: Wanling Liang, et al.
Published: (2018) -
The influence of amino acids on aztreonam spray-dried powders for inhalation
by: Xiao-Fei Yang, et al.
Published: (2015)